The Chinese General Hospital and Medical Center (CGHMC) is excited to introduce the Gamma Probe in its Department of Nuclear Medicine and Theranostics. This device enhances the precision of radioguided surgeries, helping doctors target and remove cancerous or problematic tissue with unmatched accuracy. For patients, this means safer procedures, faster recovery, and a focus on preserving their quality of life.
The Gamma Probe is especially valuable for surgeries involving breast cancer, parathyroid adenomas, and melanomas, where accuracy is crucial. By using special tracers and highly sensitive detection, it identifies affected tissue in real-time, allowing surgeons to operate with smaller incisions. This approach leads to a smoother procedure, less scarring, and less discomfort for patients.
In breast cancer and melanoma surgeries, for instance, the Gamma Probe helps identify sentinel lymph nodes, necessary for identifying cancer spread and guiding treatment. Its accuracy allows for targeted surgery, minimizing unaffected tissue removal, resulting to faster recovery.
For parathyroid adenomas, the Gamma Probe’s precise detection allows surgeons to remove only what is necessary, leaving healthy tissues untouched. This reduces both the physical and emotional impact on patients, giving them confidence in the quality of their care.
CGHMC is one of the few hospitals in the region with this advanced technology, reinforcing its commitment to providing cutting-edge care focused on patient well-being. By supporting minimally invasive techniques, the Gamma Probe helps reduce risks such as infection and lengthy recovery times, allowing patients to return to their lives more quickly.
Adding the Gamma Probe isn’t just about advanced equipment—it’s a commitment to compassionate, effective care. Patients at CGHMC can trust they’re receiving the most appropriate management for their specific condition, delivered by a dedicated team that puts their needs first.
For more information on how the Gamma Probe could benefit you or a loved one, contact the CGHMC Department of Nuclear Medicine and Theranostics at (02) 8711 4141, local 237.
